Feb 9, 2026 07:28AM

Feb 18, 2025 07:05AM

Jun 27, 2023 07:15AM

Apr 18, 2023 07:10AM

Mar 16, 2021 08:32AM

Sep 1, 2020 08:00AM

Aug 4, 2020 08:00AM Arch Biopartners Receives Independent Institutional Review Board Approval for Phase II Trial for LSALT Peptide

Jul 14, 2020 07:00AM

Jun 16, 2020 10:48AM

Jun 15, 2020 08:19AM

Jun 8, 2020 07:00AM

May 19, 2020 04:31PM

May 8, 2020 06:00AM

Apr 23, 2020 04:54PM Arch Biopartners Submits Application to Health Canada to Conduct COVID19 Phase II Human Trial for Metablok to Prevent Lung and Kidney Inflammation

Mar 4, 2020 09:56AM

Feb 21, 2020 08:00AM

Dec 18, 2019 09:27AM

Nov 7, 2019 07:00AM

Aug 22, 2019 12:24PM

Mar 19, 2019 10:06AM

Mar 19, 2019 08:46AM Arch Biopartners Receives Approval to Perform Phase I Clincial Trial for Metablok in Australia

Dec 11, 2018 08:02AM

Oct 29, 2018 09:00AM

Jun 19, 2018 08:00AM

May 22, 2018 09:11AM

May 8, 2018 09:25AM

Mar 27, 2018 09:08AM

Mar 21, 2018 08:00AM Arch Biopartners Granted Pre-Ind Meeting With FDA for Candidate Drug to Prevent Acute Kidney Injury

Feb 13, 2018 08:00AM

Oct 10, 2017 06:30AM

Sep 28, 2017 08:30AM

Jul 27, 2017 12:43PM

May 4, 2017 01:35PM

Apr 13, 2017 08:37AM

322,250 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All